ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,14
-1,42%
Bitcoin
64 831,98
-0,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOS)

  7. BioPlus Acquisition Corporation (BIOS) Actualités

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateHeureSourceTitreSymboleSociété
22/02/201814h00Business WireBioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
15/02/201822h55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
14/02/201823h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
09/02/201813h30Business WireBioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019NASDAQ:BIOSBioPlus Acquisition Corporation
01/02/201815h29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
08/01/201814h00GlobeNewswire Inc.BioScrip Announces Availability of HEMLIBRA® for Hemophilia PatientsNASDAQ:BIOSBioPlus Acquisition Corporation
01/12/201722h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
01/12/201722h28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOSBioPlus Acquisition Corporation
30/11/201714h00GlobeNewswire Inc.BioScrip to Host Meetings at the Mizuho Investor ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
28/11/201714h00GlobeNewswire Inc.BioScrip Announces Additions to Senior Leadership TeamNASDAQ:BIOSBioPlus Acquisition Corporation
16/11/201715h00GlobeNewswire Inc.BioScrip to Present at Bank of America Merrill Lynch 2017 Leveraged Finance ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
09/11/201714h00GlobeNewswire Inc.BioScrip to Host Meetings at the 8th Annual Craig-Hallum Alpha Select ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201718h13Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201715h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201713h00GlobeNewswire Inc.BioScrip Reports Third Quarter 2017 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
31/10/201713h00GlobeNewswire Inc.BioScrip to Present at Stephens Fall Investment ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
16/10/201714h00GlobeNewswire Inc.BioScrip to Host Third Quarter Results CallNASDAQ:BIOSBioPlus Acquisition Corporation
05/10/201714h00GlobeNewswire Inc.BioScrip Announces Availability of ALS Home Infusion TherapyNASDAQ:BIOSBioPlus Acquisition Corporation
28/09/201701h48Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BIOSBioPlus Acquisition Corporation
08/09/201712h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BIOSBioPlus Acquisition Corporation
08/08/201714h00GlobeNewswire Inc.BioScrip Reports Second Quarter 2017 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
27/07/201714h30GlobeNewswire Inc.First Choice Appoints New CFO to Help Lead Company Through Next Phase of Strategic ExecutionNASDAQ:BIOSBioPlus Acquisition Corporation
26/07/201714h00GlobeNewswire Inc.BioScrip Applauds US House Passage of HR3178, the Medicare Part B Improvement Act of 2017NASDAQ:BIOSBioPlus Acquisition Corporation
17/07/201715h00GlobeNewswire Inc.BioScrip To Host Second Quarter Results CallNASDAQ:BIOSBioPlus Acquisition Corporation
10/07/201712h30Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BIOSBioPlus Acquisition Corporation
29/06/201714h30GlobeNewswire Inc.BioScrip Announces New Senior Note FacilitiesNASDAQ:BIOSBioPlus Acquisition Corporation
30/05/201714h00GlobeNewswire Inc.BioScrip Provides Update on UnitedHealthcare ContractNASDAQ:BIOSBioPlus Acquisition Corporation
24/05/201714h00GlobeNewswire Inc.BioScrip to Present at the Jefferies 2017 Global Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
04/05/201714h00GlobeNewswire Inc.BioScrip Reports First Quarter 2017 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
20/04/201715h00GlobeNewswire Inc.BioScrip Announces CFO TransitionNASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
HO
Thales
EU
VIV
Vivendi
EU
BNP
BNP Paribas
NASDAQ
AAPL
Apple
EU
RI
Pernod Ricard
FTSE
UKX
FTSE 100
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
EU
EN
Bouygues
EU
CS
Axa
EU
LR
Legrand
COIN
ETHUSD
Ethereum
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés